CN112299489A - 一种超小氧化铁纳米颗粒及其制备方法及应用 - Google Patents
一种超小氧化铁纳米颗粒及其制备方法及应用 Download PDFInfo
- Publication number
- CN112299489A CN112299489A CN202011071340.5A CN202011071340A CN112299489A CN 112299489 A CN112299489 A CN 112299489A CN 202011071340 A CN202011071340 A CN 202011071340A CN 112299489 A CN112299489 A CN 112299489A
- Authority
- CN
- China
- Prior art keywords
- ultra
- iron oxide
- metal
- iron
- oxide nanoparticles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940031182 nanoparticles iron oxide Drugs 0.000 title claims abstract description 49
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 67
- 230000005291 magnetic effect Effects 0.000 claims abstract description 22
- 229910052751 metal Inorganic materials 0.000 claims abstract description 22
- 239000002184 metal Substances 0.000 claims abstract description 20
- 230000005298 paramagnetic effect Effects 0.000 claims abstract description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims abstract description 12
- 230000005294 ferromagnetic effect Effects 0.000 claims abstract description 12
- 238000002595 magnetic resonance imaging Methods 0.000 claims abstract description 10
- 239000002243 precursor Substances 0.000 claims abstract description 9
- 239000012266 salt solution Substances 0.000 claims abstract description 9
- 239000000243 solution Substances 0.000 claims abstract description 9
- 238000010438 heat treatment Methods 0.000 claims abstract description 7
- 239000011258 core-shell material Substances 0.000 claims abstract description 5
- 239000003960 organic solvent Substances 0.000 claims abstract description 5
- 239000004094 surface-active agent Substances 0.000 claims abstract description 5
- 229910016285 MxNy Inorganic materials 0.000 claims abstract description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229910052742 iron Inorganic materials 0.000 claims description 19
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 12
- 239000011701 zinc Substances 0.000 claims description 11
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 10
- 239000011572 manganese Substances 0.000 claims description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 7
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 6
- CUJRVFIICFDLGR-UHFFFAOYSA-N acetylacetonate Chemical compound CC(=O)[CH-]C(C)=O CUJRVFIICFDLGR-UHFFFAOYSA-N 0.000 claims description 6
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 6
- 229910052761 rare earth metal Inorganic materials 0.000 claims description 6
- 229910052786 argon Inorganic materials 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical compound C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 claims description 5
- 238000003384 imaging method Methods 0.000 claims description 5
- GQEZCXVZFLOKMC-UHFFFAOYSA-N 1-hexadecene Chemical compound CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 claims description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 4
- -1 Oleic acid rare earth Chemical class 0.000 claims description 4
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 claims description 4
- 229910000015 iron(II) carbonate Inorganic materials 0.000 claims description 4
- YIXJRHPUWRPCBB-UHFFFAOYSA-N magnesium nitrate Chemical compound [Mg+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O YIXJRHPUWRPCBB-UHFFFAOYSA-N 0.000 claims description 4
- 229910052748 manganese Inorganic materials 0.000 claims description 4
- 239000011667 zinc carbonate Substances 0.000 claims description 4
- 229910000010 zinc carbonate Inorganic materials 0.000 claims description 4
- 235000004416 zinc carbonate Nutrition 0.000 claims description 4
- 229910021380 Manganese Chloride Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 239000011565 manganese chloride Substances 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- CDVAIHNNWWJFJW-UHFFFAOYSA-N 3,5-diethoxycarbonyl-1,4-dihydrocollidine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1C CDVAIHNNWWJFJW-UHFFFAOYSA-N 0.000 claims description 2
- 229910021012 Co2(CO)8 Inorganic materials 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000012692 Fe precursor Substances 0.000 claims description 2
- 239000004277 Ferrous carbonate Substances 0.000 claims description 2
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 claims description 2
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 claims description 2
- 239000005642 Oleic acid Substances 0.000 claims description 2
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Natural products CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims description 2
- 229910021446 cobalt carbonate Inorganic materials 0.000 claims description 2
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 claims description 2
- ZOTKGJBKKKVBJZ-UHFFFAOYSA-L cobalt(2+);carbonate Chemical compound [Co+2].[O-]C([O-])=O ZOTKGJBKKKVBJZ-UHFFFAOYSA-L 0.000 claims description 2
- BKFAZDGHFACXKY-UHFFFAOYSA-N cobalt(II) bis(acetylacetonate) Chemical compound [Co+2].CC(=O)[CH-]C(C)=O.CC(=O)[CH-]C(C)=O BKFAZDGHFACXKY-UHFFFAOYSA-N 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 229940116318 copper carbonate Drugs 0.000 claims description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 claims description 2
- GEZOTWYUIKXWOA-UHFFFAOYSA-L copper;carbonate Chemical compound [Cu+2].[O-]C([O-])=O GEZOTWYUIKXWOA-UHFFFAOYSA-L 0.000 claims description 2
- 239000006185 dispersion Substances 0.000 claims description 2
- RAQDACVRFCEPDA-UHFFFAOYSA-L ferrous carbonate Chemical compound [Fe+2].[O-]C([O-])=O RAQDACVRFCEPDA-UHFFFAOYSA-L 0.000 claims description 2
- 235000019268 ferrous carbonate Nutrition 0.000 claims description 2
- 229960004652 ferrous carbonate Drugs 0.000 claims description 2
- MEANOSLIBWSCIT-UHFFFAOYSA-K gadolinium trichloride Chemical compound Cl[Gd](Cl)Cl MEANOSLIBWSCIT-UHFFFAOYSA-K 0.000 claims description 2
- MWFSXYMZCVAQCC-UHFFFAOYSA-N gadolinium(iii) nitrate Chemical compound [Gd+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O MWFSXYMZCVAQCC-UHFFFAOYSA-N 0.000 claims description 2
- LZKLAOYSENRNKR-LNTINUHCSA-N iron;(z)-4-oxoniumylidenepent-2-en-2-olate Chemical compound [Fe].C\C(O)=C\C(C)=O.C\C(O)=C\C(C)=O.C\C(O)=C\C(C)=O LZKLAOYSENRNKR-LNTINUHCSA-N 0.000 claims description 2
- 230000007774 longterm Effects 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 2
- 239000001095 magnesium carbonate Substances 0.000 claims description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 2
- 239000002122 magnetic nanoparticle Substances 0.000 claims description 2
- 239000011656 manganese carbonate Substances 0.000 claims description 2
- 235000006748 manganese carbonate Nutrition 0.000 claims description 2
- 229940093474 manganese carbonate Drugs 0.000 claims description 2
- 235000002867 manganese chloride Nutrition 0.000 claims description 2
- 229940099607 manganese chloride Drugs 0.000 claims description 2
- 229910000016 manganese(II) carbonate Inorganic materials 0.000 claims description 2
- XMWCXZJXESXBBY-UHFFFAOYSA-L manganese(ii) carbonate Chemical compound [Mn+2].[O-]C([O-])=O XMWCXZJXESXBBY-UHFFFAOYSA-L 0.000 claims description 2
- XTAZYLNFDRKIHJ-UHFFFAOYSA-N n,n-dioctyloctan-1-amine Chemical compound CCCCCCCCN(CCCCCCCC)CCCCCCCC XTAZYLNFDRKIHJ-UHFFFAOYSA-N 0.000 claims description 2
- DAHPIMYBWVSMKQ-UHFFFAOYSA-N n-hydroxy-n-phenylnitrous amide Chemical compound O=NN(O)C1=CC=CC=C1 DAHPIMYBWVSMKQ-UHFFFAOYSA-N 0.000 claims description 2
- 229910052759 nickel Inorganic materials 0.000 claims description 2
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 claims description 2
- 229910000008 nickel(II) carbonate Inorganic materials 0.000 claims description 2
- ZULUUIKRFGGGTL-UHFFFAOYSA-L nickel(ii) carbonate Chemical compound [Ni+2].[O-]C([O-])=O ZULUUIKRFGGGTL-UHFFFAOYSA-L 0.000 claims description 2
- CCCMONHAUSKTEQ-UHFFFAOYSA-N octadecene Natural products CCCCCCCCCCCCCCCCC=C CCCMONHAUSKTEQ-UHFFFAOYSA-N 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- SVMGVNXXUVNGRK-UHFFFAOYSA-N oxomethylideneiron Chemical compound O=C=[Fe] SVMGVNXXUVNGRK-UHFFFAOYSA-N 0.000 claims description 2
- 229910001848 post-transition metal Inorganic materials 0.000 claims description 2
- 150000002910 rare earth metals Chemical class 0.000 claims description 2
- 229910052723 transition metal Inorganic materials 0.000 claims description 2
- 150000003624 transition metals Chemical class 0.000 claims description 2
- 229940043825 zinc carbonate Drugs 0.000 claims description 2
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 claims 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 abstract description 24
- 239000002105 nanoparticle Substances 0.000 abstract description 14
- 238000006243 chemical reaction Methods 0.000 abstract description 5
- 238000001816 cooling Methods 0.000 abstract description 4
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 abstract description 4
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 238000005406 washing Methods 0.000 abstract description 3
- 239000011261 inert gas Substances 0.000 abstract 2
- 239000000047 product Substances 0.000 description 14
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- 238000005119 centrifugation Methods 0.000 description 6
- 239000012467 final product Substances 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 239000002872 contrast media Substances 0.000 description 5
- 229910052688 Gadolinium Inorganic materials 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 4
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 3
- 229910021645 metal ion Inorganic materials 0.000 description 3
- 229940055577 oleyl alcohol Drugs 0.000 description 3
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 229910001566 austenite Inorganic materials 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000005415 magnetization Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229910006297 γ-Fe2O3 Inorganic materials 0.000 description 2
- 229910021592 Copper(II) chloride Inorganic materials 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical compound [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- XYXLRVFDLJOZJC-CVBJKYQLSA-L manganese(2+);(z)-octadec-9-enoate Chemical compound [Mn+2].CCCCCCCC\C=C/CCCCCCCC([O-])=O.CCCCCCCC\C=C/CCCCCCCC([O-])=O XYXLRVFDLJOZJC-CVBJKYQLSA-L 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 201000002793 renal fibrosis Diseases 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 229910000859 α-Fe Inorganic materials 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G49/00—Compounds of iron
- C01G49/02—Oxides; Hydroxides
- C01G49/06—Ferric oxide [Fe2O3]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/183—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an inorganic material or being composed of an inorganic material entrapping the MRI-active nucleus, e.g. silica core doped with a MRI-active nucleus
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G49/00—Compounds of iron
- C01G49/0018—Mixed oxides or hydroxides
- C01G49/0063—Mixed oxides or hydroxides containing zinc
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G49/00—Compounds of iron
- C01G49/0018—Mixed oxides or hydroxides
- C01G49/0072—Mixed oxides or hydroxides containing manganese
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/01—Particle morphology depicted by an image
- C01P2004/04—Particle morphology depicted by an image obtained by TEM, STEM, STM or AFM
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
- C01P2004/61—Micrometer sized, i.e. from 1-100 micrometer
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/80—Particles consisting of a mixture of two or more inorganic phases
- C01P2004/82—Particles consisting of a mixture of two or more inorganic phases two phases having the same anion, e.g. both oxidic phases
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nanotechnology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Radiology & Medical Imaging (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Composite Materials (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Materials Engineering (AREA)
- Compounds Of Iron (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
本发明公开了一种超小氧化铁纳米颗粒,所述超小磁性氧化铁纳米颗粒为由内部自旋有序的铁磁核及表面自旋无序的顺磁壳层组成的MxFe3‑xO4@MxNyFe3‑x‑yO4核‑壳结构且组分可调。本发明还提供了上述超小氧化铁纳米颗粒的制备方法,将两种金属前驱体、表面活性剂按照比例溶于有机溶剂中形成均匀的反应体系,在惰性气体氛围内加热到200‑280℃后,冷却降温,离心洗涤分散于四氢呋喃溶液中,之后加入金属盐溶液,惰性气体氛围内加热到50‑70℃后,离心洗涤即可。本发明属于磁性氧化铁技术领域,本发明提供的超小氧化铁纳米颗粒可同时调控铁磁内核以及顺磁表面的组分,可实现弛豫率的协同增强,可更好的应用于磁共振成像领域。
Description
技术领域
本发明属于磁性氧化铁技术领域,具体是指一种超小氧化铁纳米颗粒及其制备方法及应用。
背景技术
近年来,超小磁性氧化铁纳米颗粒由于其优异的造影性能,良好的生物安全性,有望取代现有临床钆基造影剂成为新一代磁共振T1造影剂。为了制备高度单分散,造影性能优异的磁性氧化铁纳米颗粒,韩国首尔大学Taeghwan Hyeon课题组发表的J.Am.Chem.Soc.2011,133,12624,中国发明专利(CN103153348B);中国科学院化学所高明远课题组发表的Nanotechnology.2011,22,245604;Li,Z.Adv.Funct.Mater.2012,22,2387;Adv.Heathcare.Mater.2013,2,958.等文件都公开报道了制备尺寸形貌均匀的超小氧化铁、铁氧体纳米颗粒。
虽然通过以上方法制备的超小氧化铁纳米颗粒尺寸形貌均一,可以作为磁共振成像T1造影剂,但是这些超小氧化铁纳米颗粒作为磁共振成像T1造影剂依然存在着成像灵敏度不足的问题。为提高超小氧化铁纳米颗粒的T1造影性能,有报道将含钆的物质掺杂到超小氧化铁内部(ACS Nano.2013,7,3287)从而诱导内部产生自旋倾斜效应,提高其T1造影性能,但由于钆从纳米颗粒中的泄露容易造成患者肾源系统纤维化甚至肾衰竭,并在体内长期滞留在中枢神经系统,对人体构成潜在风险。因此,也有人采用其他金属离子掺杂的报道,如利用Zn2+的掺杂,提高氧化铁纳米颗粒的饱和磁化强度(Angew Chem Int Ed,2009,48,1234;Chem Commun,2008,19,2224),进而提高提高其造影性能,如其中15nm的Zn0.4Fe2.6O4纳米颗粒在4.5T下的r2值高达860mM-1s-1,是Fe3O4纳米颗粒的2.5倍。最近,厦门大学高锦豪课题组通过Mn2+掺杂增加可提高氧化铁纳米颗粒T1弛豫率,报道了不同形貌,不同大小纳米颗粒作为磁共振T1造影剂(J Mater Chem B,2018,6,401,Nanoscale,2014,6,10404)。锰铁氧体立方块的r1值在0.5T下为57.8mM-1s-1,是相同尺寸的氧化铁纳米颗粒3.5倍,以上研究表明均匀掺杂金属离子的方法能够提高超小氧化铁纳米颗粒的T1造影性能。
为了进一步提高超小氧化铁纳米颗粒的T1造影性能,本发明提供一种在超小氧化铁纳米颗粒均匀掺杂的基础上,调控超小氧化铁纳米颗粒的顺磁表面组分,进一步提高超小氧化铁纳米颗粒成像弛豫率,实现超小氧化铁纳米颗粒中核壳的组分协同增强效果的方法,并将其更好的应用于磁共振成像领域。本发明提供的可调控铁磁内核及顺磁表面组分的超小氧化铁纳米颗粒,调控铁磁内核的组分可调节超小氧化铁纳米颗粒的饱和磁化强度(Ms),从而调控弛豫率外球模型的贡献;调控顺磁表面的组分可调节超小氧化铁纳米颗粒与水分子的交换速率,从而调控弛豫率内球模型的贡献。这种同时调节内外球模型贡献的策略可以实现弛豫率的协同增强。
发明内容
为了解决上述难题,本发明提供了一种在超小氧化铁纳米颗粒均匀掺杂的基础上,调控超小氧化铁纳米颗粒的顺磁表面组分,来进一步提高超小氧化铁纳米颗粒成像弛豫率的方法,并将其应用于磁共振成像。
为了实现上述功能,本发明采取的技术方案如下:一种超小氧化铁纳米颗粒,所述超小磁性氧化铁纳米颗粒为由内部自旋有序的铁磁内核及表面自旋无序的顺磁壳层组成的MxFe3-xO4@MxNyFe3-x-yO4核-壳结构且铁磁内核及顺磁壳层的组分可调,所述M为Fe、Co、Ni、Mn、Cu、Zn、Mg、Ca中的一种,x值为0-1.5,所述N为稀土金属、第四周期过渡金属和后过渡金属中的一种,y值为0-0.5。
进一步地,所述超小磁性氧化铁纳米颗粒粒径为2-6nm。
为了实现上述目的,本发明还提供了超小氧化铁纳米颗粒的制备方法,包括以下步骤:
S1、在50ml三口烧瓶中加入铁的前驱体、另一种金属M前驱体、表面活性剂和有机溶剂,升温至200-280℃,保温0-1h,将所得产物采用离心-分散的方式进行3-5次清洗,收集产物分散于正己烷中。
S2、取一定量S1中所得产物,一定量的金属N盐溶液,加入一定体积的四氢呋喃溶液中,通入氩气,50-70℃保持10-60min。
S3、将S2中产物离心洗涤,保存。
进一步地,S1中所述铁的前驱体包括含铁有机配合物和含铁的碳酸盐,S1中所述另一种金属M前驱体包括金属有机配合物和金属碳酸盐;
其中,所述含铁有机配合物包括:芥酸铁、乙酰丙酮铁Fe(acac)3、油酸铁Fe(OA)3、羰基合铁Fe(CO)5、亚硝基羟基苯胺合铁FeCup3;所述铁的碳酸盐为FeCO3;
其中,所述另一种金属M前驱体包括:乙酰丙酮铁Fe(acac)3、油酸铁Fe(OA)3、五羰基合铁Fe(CO)5、亚硝基羟基苯胺合铁FeCup3、Co2(CO)8、Co(acac)2、Ni(OOCCH3)2、Ni(acac)2、油酸稀土配合物、乙酰丙酮稀土配合物;所述金属碳酸盐包括碳酸锌、碳酸亚铁、碳酸锰、碳酸钴、碳酸镍、碳酸镁和碳酸铜。
进一步地,S1中所述表面活性剂包括碳链长度介于6-25之间的有机酸、碳链长度介于6-25之间的有机胺和碳链长度介于6-25之间的有机醇,S1中所述有机溶剂包括十八烯、苄醚、十六碳烯、辛醚和三辛胺。
进一步地,S2中所述金属盐溶液包括氯化锰、氯化钆、氯化铜、氯化镍、氯化钴、氯化镁、硝酸钆和硝酸镁的金属盐溶液。
本发明提供了通过上述方法合成的超小氧化铁纳米颗粒的应用,可以应用于磁共振成像、细胞长期跟踪以及磁纳米颗粒成像领域。
与现有技术相比,本发明还提供了核壳结构的超小氧化铁纳米颗粒制备方法,首先通过热分解法实现金属离子在超小磁性氧化铁铁磁内核的掺杂,然后通过温和的阳离子交换反应实现超小磁性氧化铁顺磁表面组分的调控;本发明提供的可同时调控铁磁内核以及顺磁表面的组分的超小氧化铁纳米颗粒,可实现弛豫率的协同增强,因而能够更好的应用于磁共振成像领域。
附图说明
图1为本发明实施例1的超小磁性氧化铁纳米颗粒透射电镜(TEM)图;
图2为本发明实施例1的超小磁性氧化铁纳米颗粒金属元素分布图;
图3为本发明实施例1和实施例3的超小磁性氧化铁纳米颗粒T1弛豫率图;
图4为本发明实施例1和实施例3的超小磁性氧化铁纳米颗粒弛豫速率r1结果柱状图。
具体实施方式
下面结合具体实施对本发明的技术方案进行进一步详细地说明,本发明所述的技术特征没有进行详细描述的部分均为采用的现有技术。
结合以下实施例,对本发明做进一步详细说明。
实施例1
超小氧化铁纳米颗粒(Zn0.4Fe2.6O4@Zn0.4Mn0.2Fe2.4O4)的制备
(1)称量2.14g芥酸铁,0.09g碳酸锌,3.22g油醇,加入10mL苄醚中,置于50ml三口烧瓶内,270℃保温30min,至溶液呈澄清透亮黑褐色,反应结束;
(2)降温至50℃以下,采用氯仿分散-离心的方式对产物进行三次清洗,最终产物分散于10mL正己烷中;
(3)取1ml(2)中所得产物,5mg MnCl2,加入5ml THF,在氩气保护下升温至50℃,保温30min;
(4)采用氯仿分散-离心的方式对产物进行三次清洗,最终产物分散于10mL正己烷中。
对所制备的超小氧化铁纳米颗粒(Zn0.4Fe2.6O4@Zn0.4Mn0.2Fe2.4O4)进行一系列表征,具体是将所制备的超小氧化铁纳米颗粒分散在正己烷中,取2μL分散有纳米颗粒的正己烷溶液滴在镀有碳膜的Cu网上,自然干燥后做表征。图1为透射电镜图,从图1中可以看出,超小氧化铁纳米颗粒大小形貌均一,具有单分散性,尺寸在3.8nm左右;图2为金属元素分布图,从图2中可以看出超小氧化铁纳米颗粒含有Mn、Fe和Zn元素。
实施例2
超小氧化铁纳米颗粒(Zn0.9Fe2.1O4@Zn0.9Gd0.2Fe1.9O4)的制备
(1)称量2.14g芥酸铁,0.3g碳酸锌,3.22g油醇,加入10mL苄醚中,置于50ml三口烧瓶内,270℃保温30min,至溶液呈澄清透亮黑褐色,反应结束;
(2)降温至50℃以下,采用氯仿分散-离心的方式对产物进行三次清洗,最终产物分散于10mL正己烷中;
(3)取1ml(2)中所得产物,8mg Gd(NO)3,加入5ml THF,在氩气保护下升温至60℃,保温30min;
(4)采用氯仿分散-离心的方式对产物进行三次清洗,最终产物分散于10mL正己烷中。
实施例3
超小氧化铁纳米颗粒(MnFe2O4@MnCu0.1Fe1.9O4)的制备
(1)称量1.07g芥酸铁,1.1g油酸锰,3.22g油醇,加入10mL苄醚中,置于50ml三口烧瓶内,250℃保温30min,至溶液呈澄清透亮黑褐色,反应结束;
(2)降温至50℃以下,采用氯仿分散-离心的方式对产物进行三次清洗,最终产物分散于10mL正己烷中;
(3)取1ml(2)中所得产物,5mg CuCl2,加入5ml THF,在氩气保护下升温至50℃,保温30min;
(4)采用氯仿分散-离心的方式对产物进行三次清洗,最终产物分散于10mL正己烷中。
实施例4
将实施例1制备的调控铁磁内核及顺磁表面组分的超小氧化铁纳米颗粒(Zn0.4Fe2.6O4@Zn0.4Mn0.2Fe2.4O4)和常规超小氧化铁纳米颗粒(γ-Fe2O3)分散在水中,使其Fe浓度分别为0.0625、0.125、0.25、0.5和1mM。分别取10mL颗粒溶液,使用3T磁共振成像仪(Siemens,Germany)进行扫描。MRI扫描参数为:TR=4000ms,TE=19ms。得到样品磁共振扫描图像后,计算出不同浓度梯度样品的弛豫时间T1值如图3所示,进而求出弛豫速率r1如图4所示。经计算调控铁磁内核及顺磁表面组分的超小氧化铁纳米颗粒(Zn0.4Fe2.6O4@Zn0.4Mn0.2Fe2.4O4)和常规超小氧化铁纳米颗粒(γ-Fe2O3)的r1分别为20.22mM-1s-1和3.92mM-1s-1,Zn0.4Fe2.6O4@Zn0.4Mn0.2Fe2.4O4的r1是γ-Fe2O3的5倍以上,说明Zn0.4Fe2.6O4@Zn0.4Mn0.2Fe2.4O4 MRI的T1造影性能远远高于γ-Fe2O3。
以上对本发明及其实施方式进行了描述,这种描述没有限制性,附图中所示的也只是本发明的实施方式之一,并不局限于此。总而言之如果本领域的普通技术人员受其启示,在不脱离本发明创造宗旨的情况下,不经创造性的设计出与该技术方案相似的结构方式及实施例,均应属于本发明的保护范围。
Claims (7)
1.一种超小氧化铁纳米颗粒,其特征在于,所述超小磁性氧化铁纳米颗粒为由内部自旋有序的铁磁内核及表面自旋无序的顺磁壳层组成的MxFe3-xO4@MxNyFe3-x-yO4核-壳结构且铁磁内核及顺磁壳层的组分可调,所述M为Fe、Co、Ni、Mn、Cu、Zn、Mg、Ca中的一种,x值为0-1.5,所述N为稀土金属、第四周期过渡金属和后过渡金属中的一种,y值为0-0.5。
2.根据权利要求1所述的一种超小氧化铁纳米颗粒,其特征在于,所述超小磁性氧化铁纳米颗粒粒径为2-6nm。
3.一种超小氧化铁纳米颗粒的制备方法,其特征在于,包括以下步骤:
S1、在50ml三口烧瓶中加入铁的前驱体、另一种金属M前驱体、表面活性剂和有机溶剂,升温至200-280℃,保温0-1h,将所得产物采用离心-分散的方式进行3-5次清洗,收集产物分散于正己烷中。
S2、取一定量S1中所得产物,一定量的金属N盐溶液,加入一定体积的四氢呋喃溶液中,通入氩气,50-70℃保持10-60min。
S3、将S2中产物离心,保存。
4.根据权利要求3所述的一种超小氧化铁纳米颗粒的制备方法,其特征在于,S1中所述铁的前驱体包括含铁有机配合物和含铁的碳酸盐,S1中所述另一种金属M前驱体包括金属有机配合物和金属碳酸盐;
所述含铁有机配合物包括:芥酸铁、乙酰丙酮铁Fe(acac)3、油酸铁Fe(OA)3、羰基合铁Fe(CO)5、亚硝基羟基苯胺合铁FeCup3;所述铁的碳酸盐为FeCO3;
所述另一种金属M前驱体包括:乙酰丙酮铁Fe(acac)3、油酸铁Fe(OA)3、五羰基合铁Fe(CO)5、亚硝基羟基苯胺合铁FeCup3、Co2(CO)8、Co(acac)2、Ni(OOCCH3)2、Ni(acac)2、油酸稀土配合物、乙酰丙酮稀土配合物;所述金属碳酸盐包括碳酸锌、碳酸亚铁、碳酸锰、碳酸钴、碳酸镍、碳酸镁和碳酸铜。
5.根据权利要求3所述的一种超小氧化铁纳米颗粒的制备方法,其特征在于,S1中所述表面活性剂包括碳链长度介于6-25之间的有机酸、碳链长度介于6-25之间的有机胺和碳链长度介于6-25之间的有机醇,S1中所述有机溶剂包括十八烯、苄醚、十六碳烯、辛醚和三辛胺。
6.根据权利要求3所述的一种超小氧化铁纳米颗粒的制备方法,其特征在于,S2中所述金属盐溶液包括氯化锰、氯化钆、氯化铜、氯化镍、氯化钴、氯化镁、硝酸钆和硝酸镁的金属盐溶液。
7.一种超小氧化铁纳米颗粒的应用,其特征在于,将权利要求1所述的超小氧化铁纳米颗粒应用于磁共振成像、细胞长期跟踪以及磁纳米颗粒成像领域。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011071340.5A CN112299489B (zh) | 2020-10-09 | 2020-10-09 | 一种超小氧化铁纳米颗粒及其制备方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011071340.5A CN112299489B (zh) | 2020-10-09 | 2020-10-09 | 一种超小氧化铁纳米颗粒及其制备方法及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112299489A true CN112299489A (zh) | 2021-02-02 |
CN112299489B CN112299489B (zh) | 2022-10-28 |
Family
ID=74489478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011071340.5A Active CN112299489B (zh) | 2020-10-09 | 2020-10-09 | 一种超小氧化铁纳米颗粒及其制备方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112299489B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113230418A (zh) * | 2021-05-12 | 2021-08-10 | 中国药科大学 | 一种超小核壳结构铁纳米颗粒的制备方法及应用 |
CN114533903A (zh) * | 2022-01-19 | 2022-05-27 | 西安超磁纳米生物科技有限公司 | 基于表面配体和表面离子介导的靶向纳米探针及其应用 |
CN115520907A (zh) * | 2022-04-14 | 2022-12-27 | 西安超磁纳米生物科技有限公司 | 一种具有活性基团的超小铁氧体纳米颗粒及其制备与应用 |
CN115838187A (zh) * | 2022-12-14 | 2023-03-24 | 西安超磁纳米生物科技有限公司 | 一种微波辅助有机相超小铁氧体纳米颗粒及制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012018240A2 (en) * | 2010-08-05 | 2012-02-09 | Hanwha Chemical Corporation | Preparation of extremely small and uniform sized, iron oxide-based paramagnetic or pseudo-paramagnetic nanoparticles and mri t1 contrast agents using the same |
CN103083688A (zh) * | 2013-01-30 | 2013-05-08 | 上海师范大学 | 一种核壳结构铁酸盐类磁性纳米复合材料及其制备方法和应用 |
US20140234226A1 (en) * | 2014-05-06 | 2014-08-21 | Morteza Mahmoudi | Plasmonic stable fluorescence superparamagnetic iron oxide nanoparticles and a method of synthesizing the same |
CN104147984A (zh) * | 2013-05-15 | 2014-11-19 | 安徽出入境检验检疫局检验检疫技术中心 | 一种单分散厚度可控的磁性核壳聚合物的制备方法 |
CN104623658A (zh) * | 2014-12-29 | 2015-05-20 | 上海师范大学 | 一种水溶性铁酸盐复合纳米粒子及其制备方法和应用 |
-
2020
- 2020-10-09 CN CN202011071340.5A patent/CN112299489B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012018240A2 (en) * | 2010-08-05 | 2012-02-09 | Hanwha Chemical Corporation | Preparation of extremely small and uniform sized, iron oxide-based paramagnetic or pseudo-paramagnetic nanoparticles and mri t1 contrast agents using the same |
US20130164222A1 (en) * | 2010-08-05 | 2013-06-27 | Hanwha Chemical Corporation | Preparation of Extremely Small and Uniform Sized, Iron Oxide-Based Paramagnetic or Pseudo-Paramagnetic Nanoparticles and MRI T1 Contrast Agents Using the Same |
CN103083688A (zh) * | 2013-01-30 | 2013-05-08 | 上海师范大学 | 一种核壳结构铁酸盐类磁性纳米复合材料及其制备方法和应用 |
CN104147984A (zh) * | 2013-05-15 | 2014-11-19 | 安徽出入境检验检疫局检验检疫技术中心 | 一种单分散厚度可控的磁性核壳聚合物的制备方法 |
US20140234226A1 (en) * | 2014-05-06 | 2014-08-21 | Morteza Mahmoudi | Plasmonic stable fluorescence superparamagnetic iron oxide nanoparticles and a method of synthesizing the same |
CN104623658A (zh) * | 2014-12-29 | 2015-05-20 | 上海师范大学 | 一种水溶性铁酸盐复合纳米粒子及其制备方法和应用 |
Non-Patent Citations (1)
Title |
---|
GABRIEL C. LAVORATO ET AL.: ""Origin and Shell-Driven Optimization of the Heating Power in Core/Shell Bimagnetic Nanoparticles"", 《ACS APPL. NANO MATER.》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113230418A (zh) * | 2021-05-12 | 2021-08-10 | 中国药科大学 | 一种超小核壳结构铁纳米颗粒的制备方法及应用 |
CN114533903A (zh) * | 2022-01-19 | 2022-05-27 | 西安超磁纳米生物科技有限公司 | 基于表面配体和表面离子介导的靶向纳米探针及其应用 |
CN115520907A (zh) * | 2022-04-14 | 2022-12-27 | 西安超磁纳米生物科技有限公司 | 一种具有活性基团的超小铁氧体纳米颗粒及其制备与应用 |
CN115838187A (zh) * | 2022-12-14 | 2023-03-24 | 西安超磁纳米生物科技有限公司 | 一种微波辅助有机相超小铁氧体纳米颗粒及制备方法 |
CN115838187B (zh) * | 2022-12-14 | 2024-06-04 | 西安超磁纳米生物科技有限公司 | 一种微波辅助有机相超小铁氧体纳米颗粒及制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN112299489B (zh) | 2022-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112299489B (zh) | 一种超小氧化铁纳米颗粒及其制备方法及应用 | |
Frey et al. | Magnetic nanoparticles: synthesis, functionalization, and applications in bioimaging and magnetic energy storage | |
Cai et al. | Green synthesis of soya bean sprouts-mediated superparamagnetic Fe3O4 nanoparticles | |
US9352058B2 (en) | Method of preparing iron oxide nanoparticles coated with hydrophilic material, and magnetic resonance imaging contrast agent using the same | |
CN103153348B (zh) | 极其小且均匀尺寸的氧化铁基顺磁性或伪顺磁性纳米颗粒的制备和使用所述纳米颗粒的mri t1显影剂 | |
Patel et al. | Cu2+-labeled, SPION loaded porous silica nanoparticles for cell labeling and multifunctional imaging probes | |
Sharma et al. | Synthesis and ageing effect in FeO nanoparticles: Transformation to core–shell FeO/Fe3O4 and their magnetic characterization | |
CN111072070B (zh) | 一种高饱和磁化超顺磁多孔铁氧体微球的制备方法 | |
Ahmadi et al. | Kinetics of magnetite nanoparticles formation in a one step low temperature hydrothermal process | |
Mendoza‐Garcia et al. | Recent advances in the high‐temperature chemical synthesis of magnetic nanoparticles | |
Wu et al. | Preparation and magnetic properties of cobalt nanoparticles with dendrimers as templates | |
CN101475224A (zh) | 聚乙烯吡咯烷酮修饰超顺磁性纳米氧化铁的制备法及用途 | |
Liu et al. | Synthesis and magnetic properties of shuriken-like nickel nanoparticles | |
Akbari et al. | FePt3/CoFe2O4 core/shell nanostructures and their magnetic properties | |
CN106395914B (zh) | 油酸包裹的超顺磁性纳米Fe3O4及其制备方法 | |
CN109399727B (zh) | 含金属原子簇的磁性氧化铁纳米颗粒及其制备和应用 | |
Yang et al. | Synthesis and characterization of superparamagnetic iron nanocomposites by hydrazine reduction | |
Tzitzios et al. | Synthesis and characterization of L10 FePt nanoparticles from Pt–Fe3O4 core-shell nanoparticles | |
Jeon et al. | Cleaved iron oxide nanoparticles as T2 contrast agents for magnetic resonance imaging | |
Pezeshki-Nejad et al. | Influence of the surfactant and annealing rate on the morphology, magnetic and structural characteristics of Co2FeAl nanoparticles | |
Ali et al. | Size and shape control synthesis of iron oxide–based nanoparticles: Current status and future possibility | |
Torkashvand et al. | Polymerized graphene oxide/MnCe0. 5Fe1. 5O4 nanoferrofluid as a T2-and T2*-weighted contrast agent for magnetic resonance imaging | |
Cross et al. | Preparation and characterization of ultra-small, monodisperse CoxFe3-xO4 nanoparticles | |
CN107213474A (zh) | 一种铁基磁性纳米晶磁共振t1造影剂的制备方法及其应用 | |
TWI445550B (zh) | Magnetic composite nanoparticles having multiple reactive functional groups of the method for its preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |